Reversible gene knockdown in mice using a tight, inducible shRNA expression system.
about
Gamma-secretase activating protein is a therapeutic target for Alzheimer's diseaseCardiac and skeletal muscle defects in a mouse model of human Barth syndromeHematopoietic overexpression of FOG1 does not affect B-cells but reduces the number of circulating eosinophilsReversible suppression of an essential gene in adult mice using transgenic RNA interferencePotentiation of insulin-mediated glucose lowering without elevated hypoglycemia risk by a small molecule insulin receptor modulatorCharacterization of HTT inclusion size, location, and timing in the zQ175 mouse model of Huntington's disease: an in vivo high-content imaging studyAn inducible RNA interference system for the functional dissection of mouse embryogenesisInducible transgenic rat model for diabetes mellitus based on shRNA-mediated gene knockdown.Synthetic strategies for studying embryonic development.Inhibition of O-GlcNAcase leads to elevation of O-GlcNAc tau and reduction of tauopathy and cerebrospinal fluid tau in rTg4510 miceAccelerating cancer modeling with RNAi and nongermline genetically engineered mouse models.Genetically engineered mouse models for drug development and preclinical trials.In vivo knockdown of TAK1 accelerates bone marrow proliferation/differentiation and induces systemic inflammationToxicity modelling of Plk1-targeted therapies in genetically engineered mice and cultured primary mammalian cells.A rapid and scalable system for studying gene function in mice using conditional RNA interference.Yin and Yang of hypothalamic insulin and leptin signaling in regulating white adipose tissue metabolismConditional brain-specific knockdown of MAPK using Cre/loxP regulated RNA interference.Life in the fast lane: mammalian disease models in the genomics era.Progress on RNAi-based molecular medicines.Tafazzin knockdown in mice leads to a developmental cardiomyopathy with early diastolic dysfunction preceding myocardial noncompaction.The microcosmos of cancer.Central insulin action regulates peripheral glucose and fat metabolism in mice.Site-directed, virus-free, and inducible RNAi in embryonic stem cellsContemporary approaches for modifying the mouse genomeRNA interference and antiviral therapy.Inducible and reversible gene silencing by stable integration of an shRNA-encoding lentivirus in transgenic rats.MitoNEET-driven alterations in adipocyte mitochondrial activity reveal a crucial adaptive process that preserves insulin sensitivity in obesity.Hepatic insulin signaling regulates VLDL secretion and atherogenesis in mice.Progress and prospects for genetic modification of nonhuman primate models in biomedical research.Rapid target gene validation in complex cancer mouse models using re-derived embryonic stem cells.The PPAR pan-agonist bezafibrate ameliorates cardiomyopathy in a mouse model of Barth syndromeModeling human neurodegenerative diseases in transgenic systems.Cancer of mice and men: old twists and new tails.Inducible RNAi system and its application in novel therapeutics.Rapid validation of cancer genes in chimeras derived from established genetically engineered mouse models.Synthetic Tet-inducible small hairpin RNAs targeting hTERT or Bcl-2 inhibit malignant phenotypes of bladder cancer T24 and 5637 cells.Efficient mouse transgenesis using Gateway-compatible ROSA26 locus targeting vectors and F1 hybrid ES cells.Overexpression of miR-210 and its significance in ischemic tissue damage.Individual Variation in Conditional β Cell Ablation Mice Contributes Significant Biases in Evaluating β Cell Functional Recovery.Dose-dependent expression of claudin-5 is a modifying factor in schizophrenia.
P2860
Q24298408-B68F8F5E-CA7A-4F4A-93C3-290D479B9C5FQ24598420-1CB1659D-1C02-43FA-8A63-C105134075A9Q27313294-1362F55A-A8DF-4A71-B156-A946BF5A8E29Q28512942-16755E9F-A653-4FED-A2E0-AD08447B8DEDQ28544827-00B2A948-C73A-4922-864D-D7BF1550F779Q28546047-6117BE63-DA17-434B-9082-E4E39E651795Q28594877-6BE3E662-76EB-44F5-9377-927845DF5658Q33425855-44620A11-1D41-4E25-9863-1D2B74CD8764Q33627100-6DDA070A-D7C6-40FC-95A3-24C78C824798Q33706940-DB493FE1-1BDB-4CAF-A53C-65A630BE67A0Q33914682-5167887C-AE17-4D91-B8C4-969B73D1E67CQ34039768-9CD63A05-7110-4113-93E5-8792EF60CCEFQ34625534-D28B07E2-1EF1-4CEB-8AA8-F9A8E41787E7Q35130666-81138545-485C-4D9D-8C4A-2A80BF113432Q35627849-EBD9E6D5-7A2F-4A98-BF25-72D379B4C40BQ35659559-9BAA210C-F2E5-4F4B-9FEA-079205377081Q35891582-062A1C18-7B27-4FB5-BFD0-CEC049FCF083Q36135110-05667C31-4371-40B3-BBDE-E32D8C5AFC98Q36161380-D83346FD-E2A4-48C6-9598-952A1C47C967Q36366378-3747B8AC-66BB-4A29-B6AA-9A0317C1DD4BQ36432986-C9C0EA65-48DE-4BC4-A406-928EC7C82E72Q36597490-EE36DC9D-A046-4A77-B19D-4BE0CB9FCA1EQ36693318-278ACEE6-8173-461F-8D0C-C6C1F8A079B5Q36846842-08A091A0-CCBC-4D06-AE13-47A85D01B9B9Q36944914-55092FFC-2B36-45FF-B600-2962E1364830Q36985023-FE352316-0DAB-464C-9479-359ADB00E67DQ37100064-E613C084-EEDA-44D1-9DC7-E1DCF8C5DD9EQ37143361-F14AD217-A3C2-494E-8CA3-E7FDA1CEC180Q37271259-8A877A73-E300-4A41-9EF0-06043726E07BQ37591111-9949042D-C7FC-4E90-B2D9-CBF488072694Q37692607-3CDC8099-831A-47B1-8F57-0D3F1ED7451DQ37968206-74D1387D-C912-47D2-9DCD-C9FA26237419Q38084235-9ABBB407-932A-4E20-B8EB-15EBEB38FB1DQ38362040-3DAC5B8A-D051-46D6-BFF5-3AD3461B254DQ38556243-B9692F2F-058D-4EE3-9DC3-30E3182F922CQ38830977-748523A4-9F5C-4E50-9C26-4F5B939ABEA4Q39874162-1E2DB213-7835-4415-87AE-1CD84496F211Q41534007-180A4D13-4E08-4BFE-B7AC-2CA15B756E29Q41672966-8C9585A8-B52F-4EA3-9AB1-70B618FAB944Q41921231-8DB926FB-14C0-4C84-8674-61831E66F5EE
P2860
Reversible gene knockdown in mice using a tight, inducible shRNA expression system.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Reversible gene knockdown in mice using a tight, inducible shRNA expression system.
@ast
Reversible gene knockdown in mice using a tight, inducible shRNA expression system.
@en
type
label
Reversible gene knockdown in mice using a tight, inducible shRNA expression system.
@ast
Reversible gene knockdown in mice using a tight, inducible shRNA expression system.
@en
prefLabel
Reversible gene knockdown in mice using a tight, inducible shRNA expression system.
@ast
Reversible gene knockdown in mice using a tight, inducible shRNA expression system.
@en
P2093
P2860
P356
P1476
Reversible gene knockdown in mice using a tight, inducible shRNA expression system.
@en
P2093
Birgit Küter-Luks
Frieder Schwenk
Jost Seibler
Sandra Niehaves
P2860
P356
10.1093/NAR/GKM122
P407
P577
2007-03-21T00:00:00Z